MicroRNA-375 Suppresses the Growth and Invasion of Fibrolamellar CarcinomaSummary

MicroRNA-375 Suppresses the Growth and Invasion of Fibrolamellar CarcinomaSummary

Background & Aims: Fibrolamellar carcinoma (FLC) is a rare liver cancer that primarily affects adolescents and young adults. It is characterized by a heterozygous approximately 400-kb deletion on chromosome 19 that results in a unique fusion between DnaJ heat shock protein family member B1 (DNAJ...

Full description

Bibliographic Details
Main Authors:	Timothy A. Dinh, Mark L. Jewell, Matt Kanke, Adam Francisco, Ramja Sritharan, Rigney E. Turnham, Seona Lee, Edward R. Kastenhuber, Eliane Wauthier, Cynthia D. Guy, Raymond S. Yeung, Scott W. Lowe, Lola M. Reid, John D. Scott, Anna M. Diehl, Praveen Sethupathy
Format:	Article
Language:	English
Published:	Elsevier 2019-01-01
Series:	Cellular and Molecular Gastroenterology and Hepatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352345X19300104

Similar Items

Multiomic analysis of microRNA-mediated regulation reveals a proliferative axis involving miR-10b in fibrolamellar carcinoma
by: Adam B. Francisco, et al.
Published: (2022-06-01)

Alternative Splicing in Hepatocellular CarcinomaSummary
by: Seung Eun Lee, et al.
Published: (2020-01-01)

An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma
by: Rigney E Turnham, et al.
Published: (2019-05-01)

Unique T-Cell Populations Define Immune-Inflamed Hepatocellular CarcinomaSummary
by: Daniela Di Blasi, et al.
Published: (2020-01-01)

Road map for fibrolamellar carcinoma: progress and goals of a diversified approach
by: Kastenhuber ER, et al.
Published: (2019-01-01)

Eosinophils Exert Antitumorigenic Effects in the Development of Esophageal Squamous Cell CarcinomaSummary
by: Justin Jacobse, et al.
Published: (2023-01-01)

There Is Something Fishy About Liver Cancer: Zebrafish Models of Hepatocellular CarcinomaSummary
by: Paul J. Wrighton, et al.
Published: (2019-01-01)

DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma.
by: Rosanna K Ma, et al.
Published: (2024-03-01)

Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular CarcinomaSummary
by: Xueying Lyu, et al.
Published: (2022-01-01)

NCOA5 Haploinsufficiency in Myeloid-Lineage Cells Sufficiently Causes Nonalcoholic Steatohepatitis and Hepatocellular CarcinomaSummary
by: Yueqi Zhang, et al.
Published: (2024-01-01)

Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular CarcinomaSummary
by: Gui-Qi Zhu, et al.
Published: (2022-01-01)

Targeting USP9X–AMPK Axis in ARID1A-Deficient Hepatocellular CarcinomaSummary
by: Feng-Kun Zhang, et al.
Published: (2022-01-01)

Fibrolamellar hepatocellular carcinoma complicating ulcerative colitis with primary sclerosing cholangitis.
by: Snook, J, et al.
Published: (1989)

Mixed fibrolamellar hepatocellular carcinoma
by: Faten Limaiem, et al.
Published: (2021-06-01)

Fibrolamellar liver cancer: the modern concept
by: E. Yu. Antonova, et al.
Published: (2020-12-01)

Metastatic Fibrolamellar Hepatocellular Carcinoma to the Pancreas
by: Nicolas A. Villa, et al.
Published: (2015-07-01)

Radiotherapy for metastatic fibrolamellar hepatocellular carcinoma
by: Justin G. Peacock, et al.
Published: (2013-07-01)

Fibrolamellar Carcinoma in a young patient
by: Javier Lizardi Cervera
Published: (2002-10-01)

Fibrolamellar Carcinoma: A Multimodal Approach
by: João Vasco Barreira, et al.
Published: (2020-04-01)

TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8+ T Cells in Hepatocellular CarcinomaSummary
by: Zhouhong Ge, et al.
Published: (2021-01-01)

Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
by: Bassem Shebl, et al.
Published: (2022-09-01)

Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver
by: Gummadi J, et al.
Published: (2023-05-01)

Fibrolamellar hepatocellular carcinoma: current clinical perspectives
by: Lafaro KJ, et al.
Published: (2015-10-01)

Fibrolamellar hepatocellular carcinoma presenting with early recurrent thrombosis
by: Hacer Kundakcioglu, et al.
Published: (2022-12-01)

Hyperammonemic encephalopathy: An unusual presentation of fibrolamellar hepatocellular carcinoma
by: Nimish Thakral, et al.
Published: (2020-01-01)

miRquant 2.0: an Expanded Tool for Accurate Annotation and Quantification of MicroRNAs and their isomiRs from Small RNA-Sequencing Data
by: Kanke Matthew, et al.
Published: (2016-12-01)

Fibrolamellar hepatocellular carcinoma: a case report and gene analysis
by: Akira Watanabe, et al.
Published: (2023-09-01)

Prognostic value of the proportion of the sclerosing component in fibrolamellar liver carcinoma
by: E. Yu. Antonova, et al.
Published: (2021-12-01)

Multicentric Fibrolamellar Hepatocellular Carcinoma: A Rare Case Report
by: Mayank Goyal, et al.
Published: (2023-01-01)

An unusual cause of gastric extraluminal compression: fibrolamellar hepatocellular carcinoma
by: Dilettoso Salvatore, et al.
Published: (2013-04-01)

Fibrolamellar hepatocellular carcinoma with alpha-one antitrypsin liver disease
by: Al Bugami Muneera, et al.
Published: (2004-01-01)

miRNA-214-3p stimulates carcinogen-induced mammary epithelial cell apoptosis in mammary cancer-resistant species
by: Rebecca M. Harman, et al.
Published: (2023-10-01)

Recruitment of BAG2 to DNAJ-PKAc scaffolds promotes cell survival and resistance to drug-induced apoptosis in fibrolamellar carcinoma
by: Sophia M. Lauer, et al.
Published: (2024-02-01)

Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors
by: Krista Y. Chen, et al.
Published: (2022-10-01)

Fibrolamellar hepatocellular carcinoma: a rare entity diagnosed by abdominal ultrasound
by: Esther Estrella-Díez, et al.

Utility of cytokeratin7 immunocytochemistry in the cytopathological diagnosis of fibrolamellar hepatocellular carcinoma
by: Rashi Garg, et al.
Published: (2018-01-01)

Fibrolamellar hepatocellular carcinoma treated with atezolizumab and bevacizumab: two case reports
by: Ali AL Zahrani, et al.
Published: (2021-03-01)

Frequent and distinct aberrations of DNA methylation patterns in fibrolamellar carcinoma of the liver.
by: Wolfgang Tränkenschuh, et al.
Published: (2010-01-01)

Repeated metastasectomy in an adolescent with fibrolamellar hepatocellular carcinoma: A case report
by: Shaheed Merani, et al.
Published: (2016-05-01)

β‐catenin cancer–enhancing genomic regions axis is involved in the development of fibrolamellar hepatocellular carcinoma
by: Ruhi Gulati, et al.
Published: (2022-10-01)